Bio Green Med Solution, Inc. (BGMS)
0.88
0.00 (0.00%)
USD |
NASDAQ |
Oct 05, 16:00
0.88
0.00 (0.00%)
After-Hours: 20:00
Bio Green Med Solution Enterprise Value : 2.038M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.038M |
| October 01, 2026 | 2.199M |
| September 30, 2026 | 2.052M |
| September 29, 2026 | 2.038M |
| September 28, 2026 | 2.194M |
| September 25, 2026 | 2.303M |
| September 24, 2026 | 2.468M |
| September 23, 2026 | 2.582M |
| September 22, 2026 | 2.354M |
| September 21, 2026 | 2.490M |
| September 18, 2026 | 2.416M |
| September 17, 2026 | 2.026M |
| September 16, 2026 | 2.768M |
| September 15, 2026 | 3.183M |
| September 14, 2026 | 2.155M |
| September 11, 2026 | 1.985M |
| September 10, 2026 | 1.807M |
| September 09, 2026 | 1.872M |
| September 08, 2026 | 1.992M |
| September 04, 2026 | 2.194M |
| September 03, 2026 | 2.314M |
| September 02, 2026 | 1.724M |
| September 01, 2026 | 1.839M |
| August 31, 2026 | 1.939M |
| August 28, 2026 | 1.906M |
| Date | Value |
|---|---|
| August 27, 2026 | 2.108M |
| August 26, 2026 | 2.088M |
| August 25, 2026 | 2.019M |
| August 24, 2026 | 1.975M |
| August 21, 2026 | 1.939M |
| August 20, 2026 | 2.007M |
| August 19, 2026 | 2.206M |
| August 18, 2026 | 2.252M |
| August 17, 2026 | 2.231M |
| August 14, 2026 | 2.270M |
| August 13, 2026 | 2.337M |
| August 12, 2026 | 2.324M |
| August 11, 2026 | 2.171M |
| August 10, 2026 | 2.166M |
| August 07, 2026 | 2.502M |
| August 06, 2026 | 2.635M |
| August 05, 2026 | 3.098M |
| August 04, 2026 | 2.700M |
| August 03, 2026 | 2.038M |
| July 31, 2026 | 2.104M |
| July 30, 2026 | 2.256M |
| July 29, 2026 | 2.038M |
| July 28, 2026 | 2.133M |
| July 27, 2026 | 2.335M |
| July 24, 2026 | 2.270M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Supermax Corp. Bhd. | 454.69M |
| YD Bio Ltd. | -- |
| ALPS Group, Inc. | -- |
| Cencora, Inc. | 68.02B |
| ACADIA Pharmaceuticals, Inc. | 2.551B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.405M |
| Revenue (Quarterly) | 0.336M |
| Total Expenses (Quarterly) | 0.741M |
| EPS Diluted (Quarterly) | -0.0759 |
| Gross Profit Margin (Quarterly) | 23.51% |
| Profit Margin (Quarterly) | -120.5% |
| Earnings Yield | -412.7% |
| Normalized Earnings Yield | -412.73 |